Business

Integra LifeSciences Announces Key Executive Leadership Appointments

Executive team further strengthened with appointments of Teshtar Elavia to the newly created chief technology officer role, Michael Hutchinson as chief legal officer, and Kerri DiPietro as chief quality officer, representing decades of experience in the MedTech industryPRINCETON, N.J., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced the appointment of Teshtar Elavia as corporate vice presiden

articleIntegra Lifesciences Holdings CorporationFebruary 17, 20264/company/integra-lifesciences-holdings/news/integra-lifesciences-announces-key-executive-leadership-appointments
Integra LifeSciences Announces Key Executive Leadership Appointments

About this update from Integra Lifesciences Holdings Corporation

[{"type":"image","alt":"Integra LifeSciences Holdings Corporation","displaySize":"","headline":null,"caption":"Integra LifeSciences Holdings Corporation","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":129,"url":"https://media.zenfs.com/en/globenewswire.com/3999864b8423e044e7c013af97c32cd2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/I_Ekfzt2.TfTXRJBnfLovQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE4MTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/3999864b8423e044e7c013af97c32cd2","width":300,"height":129}},"lazy":false},{"type":"text","content":"Executive team further strengthened with appointments of Teshtar Elavia to the newly created chief technology officer role, Michael Hutchinson as chief legal officer, and Kerri DiPietro as chief quality officer, representing decades of experience in the MedTech industry","length":270,"tagName":"p"},{"type":"text","content":"PRINCETON, N.J., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced the appointment of Teshtar Elavia as corporate vice president and chief technology officer, a newly created position to lead research and development (R&D), including product and technology development, across the company. The company also announced the appointments of Michael Hutchinson as executive vice president, chief legal officer and secretary, and Kerri DiPietro as corporate vice president and chief quality officer.","length":600,"tagName":"p"},{"type":"text","content":"The creation of the chief technology officer (CTO) position underscores Integra’s commitment to building a more connected innovation engine to advance long-term growth. As CTO, Teshtar Elavia will work to align R&D priorities with the company’s strategic imperatives, accelerate the impact and speed of product development programs, and strengthen the company’s innovation pipeline through organic and partnership efforts. He will also help identify emerging trends and technologies that reinforce the company’s market leadership and provide opportunities for future growth.","length":578,"tagName":"p"},{"type":"image","alt":"Integra LifeSciences_Teshtar Elavia_2026","displaySize":"","headline":null,"caption":"Integra LifeSciences_Teshtar Elavia_2026","className":"","disableSlideshowImg":false,"size":{"ori...

More updates from Integra Lifesciences Holdings Corporation

Michael Hutchinsonproduct developmentIntegra LifeScienceschief technology officerresearch and developmentchief legal officercorporate vice presidentKerri DiPietrostrategic imperativesTeshtar ElaviaBecton Dickinson